The safety profile of subcutaneous allergen immunotherapy in children with asthma in Hangzhou, East China.

[1]  Y. Ohya,et al.  Japanese guidelines for atopic dermatitis 2017. , 2017, Allergology international : official journal of the Japanese Society of Allergology.

[2]  Allan Linneberg,et al.  Respiratory allergy caused by house dust mites: What do we really know? , 2015, The Journal of allergy and clinical immunology.

[3]  G. Liss,et al.  AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions. , 2014, The journal of allergy and clinical immunology. In practice.

[4]  L. Wan,et al.  A Prospective Multicenter Study of Systemic Reactions in Standardized Specific Immunotherapy for Allergic Rhinitis in China , 2014, American journal of rhinology & allergy.

[5]  P. Nafstad,et al.  The prevalence of childhood asthma in China: a systematic review , 2012, BMC Public Health.

[6]  R. Lockey,et al.  Systemic reactions to subcutaneous allergen immunotherapy and the response to epinephrine. , 2011, Allergy and asthma proceedings.

[7]  Meng Xu,et al.  Systemic reactions associated with subcutaneous allergen immunotherapy: timing and risk assessment. , 2011, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[8]  C. Webber,et al.  Assessing the safety of subcutaneous immunotherapy dose adjustments. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[9]  G. Liss,et al.  Surveillance of systemic reactions to subcutaneous immunotherapy injections: year 1 outcomes of the ACAAI and AAAAI collaborative study. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[10]  R. Lockey,et al.  Speaking the same language: The World Allergy Organization Subcutaneous Immunotherapy Systemic Reaction Grading System. , 2010, The Journal of allergy and clinical immunology.

[11]  G. Passalacqua,et al.  A prospective Italian survey on the safety of subcutaneous immunotherapy for respiratory allergy , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  James T.C. Li,et al.  Allergen immunotherapy safety: characterizing systemic reactions and identifying risk factors. , 2008, Allergy and asthma proceedings.

[13]  G. Viegi,et al.  Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 * , 2008, Allergy.

[14]  S. Spector,et al.  Allergen immunotherapy: a practice parameter third update. , 2007, The Journal of allergy and clinical immunology.

[15]  J. Bousquet,et al.  Standards for practical allergen‐specific immunotherapy , 2006, Allergy.

[16]  Vernon M Chinchilli,et al.  Long-term inhaled corticosteroids in preschool children at high risk for asthma. , 2006, The New England journal of medicine.

[17]  H. Malling,et al.  Side‐effects of allergen‐specific immunotherapy. A prospective multi‐centre study , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[18]  G. Liss,et al.  Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. , 2004, The Journal of allergy and clinical immunology.

[19]  J. Cuesta-Herranz,et al.  Immunotherapy safety: a prospective multi‐centric monitoring study of biologically standardized therapeutic vaccines for allergic diseases , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[20]  Evelyn I. Milian,et al.  Allergy to house dust mites and asthma. , 2004, Puerto Rico health sciences journal.

[21]  Bénédicte Leynaert,et al.  Sensitisation to airborne moulds and severity of asthma: cross sectional study from European Community respiratory health survey , 2002, BMJ : British Medical Journal.

[22]  B. García,et al.  Allergen vaccination with a liposome-encapsulated extract of Dermatophagoides pteronyssinus: a randomized, double-blind, placebo-controlled trial in asthmatic patients. , 2002, The Journal of allergy and clinical immunology.

[23]  R. Lockey,et al.  Systemic reactions and fatalities associated with allergen immunotherapy. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[24]  H. Malling,et al.  Safety of allergen‐specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side‐effects during induction treatment , 2000, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[25]  R. N. Ross,et al.  Effectiveness of specific immunotherapy in the treatment of asthma: a meta-analysis of prospective, randomized, double-blind, placebo-controlled studies. , 2000, Clinical therapeutics.

[26]  M. Villa,et al.  Asthma self-management programmes in a population of Italian children: a multicentric study. Italian Study Group on Asthma Self-Management Programmes. , 1997, The European respiratory journal.

[27]  J. Lynn,et al.  Nonfatal systemic allergic reactions induced by skin testing and immunotherapy. , 1993, Annals of allergy.

[28]  R. Lockey,et al.  Survey of fatalities from skin testing and immunotherapy 1985-1989. , 1993, The Journal of allergy and clinical immunology.

[29]  J. Bousquet,et al.  Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol in patients suffering from asthma. , 1989, The Journal of allergy and clinical immunology.

[30]  Rui Silva,et al.  Characterisation of systemic reactions to subcutaneous immunotherapy with airborne allergens and classification according to WAO 2010. , 2015, Allergologia et immunopathologia.

[31]  A. B. Dursun,et al.  The safety of allergen immunotherapy (IT) in Turkey. , 2006, Journal of investigational allergology & clinical immunology.

[32]  I. Jáuregui,et al.  A prospective and multicenter safety-monitoring study of a short up-dosing schedule of immunotherapy with a mass-units-standardized extract of mites. , 2004, Allergologia et immunopathologia.